Browsing by Subject frataxin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
5-Jun-2020HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s AtaxiaSherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S
10-Jun-2015Identification of telomere dysfunction in Friedreich ataxia.Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M
12-Jul-2021Interruptions of the FXN GAA Repeat Tract Delay the Age at Onset of Friedreich’s Ataxia in a Location Dependent MannerNethisinghe, S; Kesavan, M; Ging, H; Labrum, R; Polke, JM; Islam, S; Garcia-Moreno, H; Callaghan, MF; Cavalcanti, F; Pook, MA; Giunti, P
26-Jan-2023A new FRDA mouse model [Fxnnull:YG8s(GAA) > 800] with more than 800 GAA repeatsKalef-Ezra, E; Edzeamey, FJ; Valle, A; Khonsari, H; Kleine, P; Oggianu, C; Al-Mahdawi, S; Pook, MA; Anjomani Virmouni, S
13-May-2026Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich’s ataxia modelsPido-Lopez, J; Moula, SE; Shaban, E; Stamatiou, K; Critchley, BJ; Whittaker, TE; Svensson, S; Anjomani Virmouni, S; Kalef-Ezra, E; Carr, L; Hassel, J; Thrasher, AJ; Kurian, MA; Blair, IA; Rojsajjakul, T; Santilli, G; Sala, A
16-May-2025Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich’s ataxia: insights from in vitro modelsEdzeamey, FJ; Ramchunder, Z; Valle Gómez, A; Ge, H; Thomas Marobbio, CM; Pourzand, C; Anjomani Virmouni, S